Testing effectiveness (Phase 2)Ended earlyNCT03189433
What this trial is testing
Efficacy and Safety Study of Ryanodex as Adjuvant Treatment in Subjects With Psychostimulant Drug-Induced Toxicity (PDIT)
Who this might be right for
Drug Toxicity Psychotropic Agents Psychostimulants
Eagle Pharmaceuticals, Inc. 2